PE eyes growth opportunities in active pharmaceutical ingredients: 5 deals

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

6 March 2026•4 mins read
LinkedInXEmail
LinkedInXEmail